IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells

International Archives of Allergy and Immunology

Volumn 121, Issue 2, 2000, Pages 144-150

  Fukagawa, Kazumi ^a,b,c   Nakajima, Toshiharu ^d   Saito, Hirohisa ^a   Tsubota, Kazuo ^b,c   Shimmura, Shigeto ^b,c   Natori, Michiya ^a   Hirai, Koichi ^d  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

^d NONE

Author keywords

Cornea; Eotaxin; IL 4; Keratoconjunctivitis, atopic; Keratoconjunctivitis, vernal

Indexed keywords

EOTAXIN; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA ULCER; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; KERATINOCYTE; KERATOCONJUNCTIVITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

EID: 0034052494     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024310     Document Type: Article

References (40)

1. Foster CS, Calonge M: Atopic keratoconjunctivitis. Ophthalmology 1990;97:992-1000.
2. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ: Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991;98:150-158.
3. Cameron JA: Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology 1995;102:985-993.
4. Montan PG, Biberfeld PJ, Scheynius A: IgE, IgE receptors, and other immunocytochemical markers in atopic and nonatopic patients with vernal keratoconjunctivitis. Ophthalmology 1995;102:725-732.
5. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M: Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146:1169-1174.
6. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K: Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol 1995;102:395-398.
7. Bonini S, Magrini L, Rotiroti G, Lambiase A, Tomassini M, Rumi C, Bonini S: The eosinophil and the eye. Allergy 1997;52:44-47.
8. Tsubota K, Takamura E, Hasegawa T, Kobayashi T: Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis. Cornea 1991;10:525-531.
9. Montan PG, van Hage-Hamsten M: Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996;80:556-560.
10. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M: Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610-613.
11. Trocme SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ: Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol 1993;115:640-643.
12. Trocme SD, Hallberg CK, Gill KS, Gleich GJ, Tyring SK, Brysk MM: Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci 1997;38:593-599.
13. Pearlman E, Lass JH, Bardenstein DS, Kopf M, Hazlett FE Jr, Diaconu E, Kazura JW: Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness). J Exp Med 1995;182:931-940.
14. Pearlman E, Lass JH, Bardenstein DS, Diaconu E, Hazlett FE Jr, Albright J, Higgins AW, Kazura JW: Onchocerca volvulus-mediated keratitis: Cytokine production by IL-4-deficient mice. Exp Parasitol 1996;54:274-281.
15. Ebisawa M, Bochner BS, Georas SN, Schleimer RP: Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol 1992;149:4021-4028.
16. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos JC, Mackay CR: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-612.
17. Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, Murphy PM, Yoshie O: Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;271:7725-7730.
18. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K: Presence of eotaxin in tears of atopic keratoconjunctivitis patients with severe corneal damage. J Allergy Clin Immunol 1999;103:1220-1221.
19. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder J-M: IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-68.
20. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, Schroder JM: Th1-and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20(4):777-786.
21. Cubitt CL, Tang Q, Monteiro CA, Lausch RN, Oakes JE: IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest Ophthalmol Vis Sci 1993;34:3199-3206.
22. Nakajima T, Yamada H, Iikura M, Miyamasu M, Izumi S, Shida H, Ohta K, Imai T, Yoshie O, Mochizuki M, Schroder JM, Morita Y, Yamamoto K, Hirai K: Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett 1998;434:226-230.
23. Miyamasu M, Nakajima T, Misaki Y, Izumi S, Tsuno N, Kasahara T, Morita Y, Yamamoto K, Hirai K: Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation. Cytokine 1999;11:751-758.
24. Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-671.
25. Chihara J, Yamada H, Takamura E, Yoshino K, Nakajima S: Possible presence of RANTES in tears of patients with allergic conjunctivitis (letter). Int Arch Allergy Immunol 1995;106: 428.
26. Fukagawa K, Saito H, Tsubota K, Shimmura S, Tachimoto H, Akasawa A, Oguchi Y: RANTES production in a conjunctival epithelial cell line. Cornea 1997;16:564-570.
27. Tran M, Tellartxe-Isusi M, Elner V, Streiter R, Lausch R, Oakes J: Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Invest Ophthalmol Vis Sci 1996; 37:987-996.
28. Marfaing-Koka A, Devergne O, Gorgone G, Portier A, Schall TJ, Galanaud P, Emilie D: Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995; 154:1870-1878.
29. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183:2349-2354.
30. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, Rao P, Ponath PD, Baggiolini M, Dahinden CA: High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin. MCP-4, and other chemokines. J Clin Invest 1997;100:1137-1143.
31. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 1994;15:127-133.
32. Dahinden CA, Geiser T, Brunner T, von Tscharner V. Caput D, Ferrara P, Minty A, Baggiolini M: Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J Exp Med 1994;179: 751-756.
33. Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, Li H, White J, Schwiebert LM, Bickel C, Liu M, Bochner BS, Williams T, Schleimer RP: Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997;99:926-936.
34. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2: 449-456.
35. Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA, Rothenberg ME, Drazen JM, Luster AD: Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997;99:1767-1773.
36. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potentially induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-2487.
37. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-480.
38. Kung TT, Stelts D, Zurcher JA, Jones H, Umland SP, Kreutner W, Egan RW, Chapman RW: Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995;12:404-409.
39. Li DQ, Tseng SCG: Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 1995;163:61-79.
40. Li DQ, Tseng SCG: Differential regulation of cytokine and receptor transcript expression in human corneal and limbal fibroblasts by epidermal growth factor. transforming growth factor-β, platelet-derived growth factor B and interleukin 1β. Invest Ophthalmol Vis Sci 1996; 37:2068-2080.